Advertisement

Topics

Latest "New England Biolabs, Inc." News Stories

01:12 EDT 16th July 2018 | BioPortfolio

Here are the most relevant search results for "New England Biolabs, Inc." found in our extensive news archives from over 250 global news sources.

More Information about New England Biolabs, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about New England Biolabs, Inc. for you to read. Along with our medical data and news we also list New England Biolabs, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of New England Biolabs, Inc. Companies for you to search.

Showing "England Biolabs" News Articles 1–25 of 1,400+

Sunday 15th July 2018

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on...   


Saturday 14th July 2018

Alte Mikroskop Präparate aus England Gehirnschnitt Vintage Microscope Slides

EUR 1,00 (0 Gebote)Angebotsende: Montag Jul-23-2018 21:06:00 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Alte Mikroskop Präparate aus England Gehirnschnitt Vintage Microscope Slides BioMarketplace You want to propose your products or a Biotech Company, a Biotech … Continue reading → Cet article Alte Mikroskop Präparate aus England Gehirnschnitt...

Friday 13th July 2018

Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film

SLOUGH, England, July 13, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted a prel...


NEB introduces NEBNext Direct Custom Ready Panels for efficient targeted re─sequencing

New England Biolabs (NEB), the industry leader in the discovery and production of enzymes for molecular biology applications, announced the launch of the NEBNext Direct Custom Ready Panels.

A New Edition of The New England Journal of Medicine Is Now Available

The New England Journal of Medicine (vol. 378, no. 17, 2018) is available online by subscription only. Articles include: “Strategies for Reducing Opioid-Overdose Deaths — Lessons from Canada” by E. Wood “Suicide: A Silent Contributor to Opioid-Overdose Deaths” by M.A. … Read More

Gender Bias in Medicine Has Far-Reaching Consequences

FRIDAY, July 13, 2018 -- Overlooking women in medicine can have far-reaching consequences, according to a perspective piece published in the June 14 issue of the New England Journal of Medicine. Lisa S. Rotenstein, M.D., M.B.A., from Brigham and...

Probiodrug (PBD-NA): Positive read-across from BAN2401 Phase II data

goetzpartners securities Limited 13-Jul-2018 / 10:27 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clien...

Vertex Refuses To Back Down On England Orkambi Deal

Vertex is staunchly defending its cystic fibrosis portfolio-based reimbursement deal rejected by NHS England and has called o...

Thursday 12th July 2018

Study examines prenatal depression in 2 generations of pregnant mothers

(JAMA Network) A study of two generations of women in England examined how common depression during pregnancy (prenatal depression) is in young mothers now compared with their mothers' generation. Depressed mood was measured using self-reported surveys in both generations and analysis of the data suggests depression in young pregnant women may be higher now than among their mothers' generation in ...

UK–US trade deal could threaten the NHS, researchers say

A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of England’s National Health Service (NHS). That’s according to researchers from the University of Michigan, the London School of Hygiene & Tropical Medicine and the University of Sheffield, whose recent opinion piece in The Lancet outlines how the USA...

NHS England’s plan to pull the plug on ineffective procedures

NHS England ​proposed last week ​to stop or reduce routine commissioning of 17 interventions, including surgery for snoring, back injections, and knee arthroscopy for osteoarthritis, in favour of...

Mauna Kea Technologies SA (MKEA-FR): Optical biopsies for increased diagnostic accuracy

goetzpartners securities Limited 12-Jul-2018 / 10:38 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clien...

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

Wednesday 11th July 2018

Geological records reveal sea-level rise threatens UK salt marshes, study says

(Rutgers University) Sea-level rise will endanger valuable salt marshes across the United Kingdom by 2100 if greenhouse gas emissions continue unabated, according to an international study co-authored by a Rutgers University-New Brunswick professor. Moreover, salt marshes in southern and eastern England face a high risk of loss by 2040, according to the study, to be published in Nature Communicati...

Global Molecular Weight Marker Market Segmented by Type of Product, Application, Marker and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global molecular weight marker market has been estimated at USD 372.72 million in 2017. The market is expected to register a CAGR of 12% during the forecast period, 2018 to 2023. North America accounted for the largest market, accounting for around 35% of the global market share, while AsiaPacific was estimated to register the fastest CAGR through the forecast period, 20182023.RD InvestmentsOn...

Victory: North East families celebrate as cancer drug giving them hope to be available on NHS – ChronicleLive

ChronicleLiveVictory: North East families celebrate as cancer drug giving them hope to be available on NHSChronicleLiveOverjoyed parents of cancer-battling children are celebrating the news that a drug giving their families hope will be made available on the NHS. The National Institute for Health and Care Excellence (NICE) has recommended dinutuximab beta to treat ...NHS will fund £150000-a-y...

EUSA Pharma: NICE Approves the Targeted Cancer Immunotherapy, QARZIBA®▼ (dinutuximab beta) to Treat Children with High-Risk Neuroblastoma

EUSA Pharma today welcomed a decision by the National Institute for Health and Care Excellence (NICE) to recommend the use of the targeted cancer immunotherapy, QARZIBA® (dinutuximab beta) to treat children with high-risk neuroblastoma within the NHS in England and Wales.i High-risk neuroblastoma is an aggressive form of neuroblastoma – the most common ...

iSchemaView Brings RAPID™ Imaging Platform to Australia and New Zealand Through Exclusive Distributor, Diagnostic Imaging Australia

State-of-the-Art Imaging Solution Provides Automated Scoring and Assessment of Brain Ischemia — Expanding the Treatment Window for Certain Acute Ischemic Strokes to Twenty-Four Hours After Onset iSchemaView, the leader in cerebrovascular imaging analysis, today announced that the company has signed Diagnostic Imaging Australia (DIA) to be the exclusi...

Immutep Limited (IMM-AU): Targeting the LAG-3 immune checkpoint

goetzpartners securities Limited 11-Jul-2018 / 10:24 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clien...

NHS England appoints national clinical advisor for primary care

NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.

Tuesday 10th July 2018

NEJM publishes final results from phase two study showing vaccines can reduce rate of sustained TB infections

(Burness) Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

Jeremy Hunt: Farewell to the great survivor

So it turns out health wasn’t his “last big job in politics” after all.1Five years, 10 months, and five days since being appointed to lead the Department of Health for England,2 Jeremy Hunt finally...

Who is Matt Hancock, England’s new health secretary?

Matt Hancock, the new secretary of state for health and social care for England, believes that political progress depends on focusing on “the big questions” and not being “drawn down rabbit...

Soccer Great (and Mom) Mia Hamm Partners with Schwan’s to Deliver Mealtime Tips & Smiles to Young Athletes & Their Families

SCHWAN’S HOME MEAL ADVANTAGE™ Campaign Marks 20 years of Supporting the National Sports Center and Young Soccer Players from around the U.S. & World Schwan’s Home Service, Inc. is partnering with legendary soccer great Mia Hamm to provide young athletes and their families with tips on serving delicious, balanced and easy-to-make meals....

Global Protein Fractionation Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The global protein fractionation market is expected to reach USD 17.56 million by 2023, witnessing a CAGR of 6.3% during 20182023 forecast period. The protein fractionation market is highly fragmented; the fractionation methods are continuously evolving and there is a continuous demand for better and costefficient techniques. Moreover, proteins are the key areas of focus for the food, pharmaceutic...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks